Related Experiment Video

Updated: Sep 26, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.9K

Young Children with Type 1 Diabetes: Recent Advances in Behavioral Research

Maureen Monaghan1,2, Breana L Bryant1, Hailey Inverso1

  • 1Children's National Hospital, 111 Michigan Ave NW, Washington, DC, 20010, USA.

Current Diabetes Reports
|April 18, 2022
PubMed

Insights

Behavioral research for young children with type 1 diabetes (T1D) is crucial as T1D rates rise. While technology improves outcomes, more research is needed to support these children and their caregivers.

Area of Science:

  • Pediatric Endocrinology
  • Behavioral Science
  • Diabetes Management

Background:

  • Rising incidence of type 1 diabetes (T1D) in young children (ages 1-7).
  • Evolving diabetes care necessitates enhanced support for young children and their caregivers.
  • Unique physiological challenges and parental stress (e.g., fear of hypoglycemia) are associated with T1D in this age group.

Purpose of the Study:

  • To provide an updated review of behavioral research concerning young children with T1D.
  • To identify current priorities and future research directions in this field.

Main Methods:

  • Review of recent behavioral research literature.
  • Analysis of trends in T1D management and technology adoption in young children.

Main Results:

  • Increased use of diabetes technology in young children has improved glycemic control and psychosocial well-being.
  • Despite positive findings in some interventions, research scope and quantity for this age group remain limited.
  • Caregiver burden and diabetes-related stress are significant factors in managing T1D in young children.

Conclusions:

  • Further research is essential to develop targeted behavioral interventions for young children with T1D.
  • Addressing caregiver needs and leveraging technology are key priorities for improving T1D management.
  • Future research should focus on expanding the scope and quantity of studies in this vulnerable population.
Abstract

Keywords:
Behavioral interventionsDiabetes technologyParentingType 1 diabetesYoung children

More Related Videos

Eye Tracking Young Children with Autism09:03

Eye Tracking Young Children with Autism

Published on: March 27, 2012

45.8K
Electrochemiluminescence Assays for Human Islet Autoantibodies09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

15.6K

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.4K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
424
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.4K
Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
448
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
813